Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 251-300 of 1328 result(s).
CYDY CytoDyn Inc
06/08/2025 2:56:12 PM
Think 5 "MOA Synergies". Far beyond (2)
CYDY CytoDyn Inc
06/08/2025 4:26:19 AM
Yep. & a non-toxic cancer-free to 5 (3)
CYDY CytoDyn Inc
06/07/2025 8:09:46 PM
Haha...knw it wasn't. Yes sir...tim (2)
CYDY CytoDyn Inc
06/07/2025 7:37:08 PM
6,8,9 months ago i agree on being a (4)
CYDY CytoDyn Inc
06/07/2025 6:30:19 PM
Should....not she
CYDY CytoDyn Inc
06/07/2025 6:21:36 PM
Mgt has done a horrible job in how (6)
CYDY CytoDyn Inc
06/07/2025 2:04:11 PM
Research and Development (R&D) Tax (3)
CYDY CytoDyn Inc
06/06/2025 12:12:59 AM
1. Potential Application of DPA to (2)
CYDY CytoDyn Inc
06/05/2025 7:20:30 PM
I don't know --- i mean taking in a (3)
CYDY CytoDyn Inc
06/05/2025 6:31:17 PM
FDA today -- included Accelerated A (6)
CYDY CytoDyn Inc
06/04/2025 9:31:25 PM
3 yrs ago -- ICI Agreement with maj (8)
CYDY CytoDyn Inc
06/04/2025 8:32:47 PM
Haha --- rgt, again x's how many ti (5)
CYDY CytoDyn Inc
06/04/2025 7:05:16 PM
Why do we have to wait until testin (2)
CYDY CytoDyn Inc
06/04/2025 6:35:34 PM
Govts/Insurance would save a stunni (3)
CYDY CytoDyn Inc
06/04/2025 5:37:41 PM
Don't forget the 2022 Right to Try (3)
CYDY CytoDyn Inc
06/04/2025 4:33:18 PM
It's estimated that at least 12 mil (2)
CYDY CytoDyn Inc
06/02/2025 11:10:26 PM
I now think like some said --- even (5)
CYDY CytoDyn Inc
06/02/2025 10:58:25 PM
Combine the CFO directives: When wa
CYDY CytoDyn Inc
06/02/2025 10:23:39 PM
Multiple loose-end trials. CFO bloc (5)
CYDY CytoDyn Inc
06/02/2025 8:54:40 PM
Forgot -- liking this part too...." (3)
CYDY CytoDyn Inc
06/02/2025 8:45:24 PM
Employment Agreement between CytoDy (6)
CYDY CytoDyn Inc
05/31/2025 12:11:01 PM
Quick look around & Dr. Tripathy is (10)
CYDY CytoDyn Inc
05/31/2025 10:58:23 AM
Another drug: Tripathy's research a (8)
CYDY CytoDyn Inc
05/31/2025 1:21:33 AM
Tripathy's work has contributed to (9)
CYDY CytoDyn Inc
05/31/2025 12:43:13 AM
Pfizer's $90b Lipitor Vs LL: The la (3)
CYDY CytoDyn Inc
05/31/2025 12:41:59 AM
This is not your typical drug/model (2)
CYDY CytoDyn Inc
05/30/2025 9:31:18 PM
Dec. letter: "Entering 2025, the Co (7)
CYDY CytoDyn Inc
05/30/2025 4:22:40 PM
Dr. Tripathy treated Mermaidgirly's (10)
CYDY CytoDyn Inc
05/30/2025 4:19:33 PM
Dr. Tripathy 2024 article: Fits als (2)
CYDY CytoDyn Inc
05/30/2025 3:48:37 PM
New SAB member ---- Did i not say w (4)
CYDY CytoDyn Inc
05/29/2025 7:43:43 PM
Cytodyn able to back date amend for
CYDY CytoDyn Inc
05/29/2025 3:03:38 PM
Table of Surrogate Endpoints That W (6)
CYDY CytoDyn Inc
05/28/2025 12:14:55 AM
March letter --- "As we approach ke (5)
CYDY CytoDyn Inc
05/26/2025 2:07:59 PM
When Cytodyn said: CytoDyn Announce (5)
CYDY CytoDyn Inc
05/26/2025 11:35:38 AM
TMZ is a chemo. Hoping we've now ra (7)
CYDY CytoDyn Inc
05/26/2025 11:15:34 AM
Aug. 25th, 2021 & PD-L1: The non-ra (7)
CYDY CytoDyn Inc
05/26/2025 1:11:51 AM
Temozolomide is the only FDA-approv (4)
CYDY CytoDyn Inc
05/25/2025 5:44:54 PM
The very last comment in our video, (3)
CYDY CytoDyn Inc
05/25/2025 12:34:58 PM
Four out of 100. That is the surviv (1)
CYDY CytoDyn Inc
05/25/2025 8:41:52 AM
*Einstein has publication decision (2)
CYDY CytoDyn Inc
05/25/2025 8:14:52 AM
TMZ / Glio is identical situation t (3)
CYDY CytoDyn Inc
05/25/2025 2:11:22 AM
Humanized mouse blood vessel data - (7)
CYDY CytoDyn Inc
05/24/2025 11:54:45 PM
The AAV Vector patent mentions BBB (2)
CYDY CytoDyn Inc
05/24/2025 11:33:09 PM
The prolongation of TMZ treatment f (7)
CYDY CytoDyn Inc
05/24/2025 1:43:51 PM
Of course agree 100%. Just wish som (3)
CYDY CytoDyn Inc
05/24/2025 1:33:18 PM
Some types of solid tumors occur on (3)
CYDY CytoDyn Inc
05/24/2025 1:18:34 PM
Nobody knows the 5/5 yet...or # of (1)
CYDY CytoDyn Inc
05/24/2025 12:50:04 PM
Acinetobacter baumannii during covi (1)
CYDY CytoDyn Inc
05/24/2025 11:51:15 AM
Patient #4 HER2+ re-post: Prior to (10)
CYDY CytoDyn Inc
05/23/2025 12:21:40 PM
In one embodiment, the administrat (4)
Go to page:
  • << First
  • < Previous
  • 5
  • 6
  • Next >

Recent Articles

  • Empowering K-12 Schools to Navigate Legal Compliance Challenges
  • Cal-Maine Foods: Earnings Report and Market Insights Ahead
  • Understanding Raynaud's Phenomenon: A Month for Awareness
  • Paychex CEO Optimistic About Continued Growth and Synergies
  • Irving-Las Colinas: Texas's Emerging Luxury Destination
  • Fluid-Aire Dynamics Achieves Remarkable Growth Recognition
  • Revolutionizing Education: Luxor's Advanced Charging Solutions
  • Active Pharmaceutical Ingredients Market Growth and Trends to Watch
  • Insights into Vertiv Holdings Co. and CVS Health Corp. Stocks
  • Jason Teichman Takes the Helm as CEO at Paessler GmbH
  • HealthPRO Canada Welcomes Health PEI to Enhance Services
  • Exciting Preparations for the 2025 Designed for Life Conference
  • Paula Cipollone Takes Charge as Chief Transformation Officer
  • Transforming $100 Into Over $1700 with Monolithic Power Systems
  • Legal Support for Quantum Investors Facing Recent Losses
  • Continuum Powders Launches New High-Performance Alloy Powder
  • Georgia Power Unveils New Contracts and Economic Growth Insights
  • Consumer Outlook Dips Amid Economic Concerns and Inflation
  • Bradley University Achieves Top Rankings for Student Success
  • Plasma Blockchain Faces 33% Drop: Market Reactions Explored
  • Radware Named a Leader in QKS Group’s Web Application Security
  • Navigating Legal Challenges in Self-Insured Health Plans
  • Unlocking the Future of Healthcare at HIMSS26 Conference
  • U.S. Coffee Market Poised for Growth: Key Insights and Trends
  • Riverside Unveils Innovative Chat-Based Video Editing Tool
  • Important Update for Lantheus Investors: Legal Actions Ahead
  • Unlocking Opportunities: Arixa Capital's New Partnership
  • Urgent Legal Insights for SelectQuote Investors – Know Your Rights
  • USAA and U.S. Bank Shine as Top Credit Cards in 2025 Rankings
  • Radware Celebrated as Top Performer in Web Application Security
  • Qnity's Innovative Solutions Set to Shine at SEMICON West 2025
  • Investors of Tronox Urged to Act Before Legal Deadline
  • Dean Curtis Earns Top Role Model Honor for Gender Equality
  • Phoenix Energy Launches Trading on NYSE American as PHXE.P
  • Lynch Carpenter's Role in Investigating Data Breach Cases
  • Strategic Growth in New Energy: Sunrise Secures Grant Funding
  • Understanding NOV Inc.'s P/E Ratio: A Comprehensive Analysis
  • Cold Stone Creamery Expands Franchise Opportunities in Houston
  • DraftKings Options Activity: What Investors Should Know
  • Burkhan Capital's $300M Investment in Robo.ai and AI Revolution
  • Understanding Oracle's Latest Options Activity and Insights
  • Georgia Power Secures Major Contracts and Looks to Future Growth
  • EchoStar Skyrockets: Analyzing Recent Trading Trends
  • Expanding Opportunities in the Global Insurance TPA Market
  • Merck's Winrevair Significantly Reduces Risk in PAH Patients
  • Transforming Patient Care: Peritoneal Dialysis Equipment Trends
  • Celebrating Two Decades of Clear Skin Innovations and Growth
  • VitalCog Expands Mental Health Initiatives with New Programs
  • Franklin School Celebrated for Innovation in Education
  • GODIVA Launches Modern Masterpiece Campaign Featuring Meester
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site